Bank of Montreal Can Boosts Stake in Lam Research Corporation $LRCX

Bank of Montreal Can lifted its position in Lam Research Corporation (NASDAQ:LRCXFree Report) by 32.3% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,852,401 shares of the semiconductor company’s stock after purchasing an additional 452,169 shares during the quarter. Bank of Montreal Can owned approximately 0.15% of Lam Research worth $248,037,000 at the end of the most recent quarter.

Several other institutional investors also recently added to or reduced their stakes in the company. Howard Hughes Medical Institute purchased a new stake in Lam Research in the second quarter valued at approximately $27,000. Sound Income Strategies LLC purchased a new position in shares of Lam Research during the third quarter worth approximately $41,000. Tripletail Wealth Management LLC acquired a new position in shares of Lam Research in the 3rd quarter valued at $44,000. Strategic Wealth Investment Group LLC purchased a new stake in Lam Research in the 2nd quarter valued at $29,000. Finally, Delos Wealth Advisors LLC purchased a new stake in Lam Research in the 2nd quarter valued at $30,000. Institutional investors and hedge funds own 84.61% of the company’s stock.

Lam Research News Summary

Here are the key news stories impacting Lam Research this week:

  • Positive Sentiment: IBM partnership announced to advance sub‑1nm logic scaling, covering novel materials, advanced processes and High‑NA EUV techniques — a strategic win that reinforces Lam’s role in next‑generation node toolsets and long‑term TAM expansion. IBM and Lam Research Announce Collaboration
  • Positive Sentiment: Barclays raised its firm price target on LRCX to $255 (equal weight) and the bank also boosted chip‑gear spending estimates — both moves support a stronger revenue outlook for wafer‑fab equipment suppliers and lift investor sentiment for Lam. Barclays Price Target Raise
  • Positive Sentiment: Inclusion in the S&P 100 (effective March 23) and a sector rebound into semiconductor‑equipment names are drawing flows into LRCX, supporting near‑term demand from passive and active investors. QuiverQuant Coverage
  • Positive Sentiment: Short interest fell ~20.7% in February to ~26.1M shares (about 2.1% of float) and days‑to‑cover is ~3.0 — reduced short exposure can remove a source of selling pressure and amplify rally momentum when demand improves. (data summary)
  • Neutral Sentiment: Industry note: analysts and outlets are reassessing valuation after a very strong 1‑year run and recent pullback; Lam’s outperformance raises questions about near‑term multiples even as fundamentals remain strong. Valuation Assessment
  • Negative Sentiment: Significant insider selling has been reported in recent months (multiple executives selling shares) and some large institutional rebalancing occurred (e.g., UBS trimmed a very large position in Q4 2025) — these can be interpreted as supply signals or portfolio adjustments that cap upside if sustained. Insider & Institutional Activity

Analysts Set New Price Targets

LRCX has been the topic of several research reports. Citic Securities raised their price objective on shares of Lam Research from $165.00 to $275.00 and gave the stock a “buy” rating in a research report on Friday, January 30th. Susquehanna set a $325.00 target price on shares of Lam Research and gave the company a “positive” rating in a report on Thursday, January 29th. Mizuho set a $265.00 target price on shares of Lam Research in a research note on Wednesday, January 28th. TD Cowen boosted their price target on Lam Research from $170.00 to $290.00 and gave the company a “buy” rating in a research report on Thursday, January 29th. Finally, Zacks Research raised Lam Research from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, January 20th. One analyst has rated the stock with a Strong Buy rating, twenty-eight have given a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat, Lam Research presently has an average rating of “Moderate Buy” and a consensus target price of $245.35.

View Our Latest Stock Analysis on Lam Research

Lam Research Price Performance

Shares of NASDAQ:LRCX opened at $215.23 on Wednesday. Lam Research Corporation has a 52 week low of $56.32 and a 52 week high of $256.68. The company has a 50-day moving average price of $222.49 and a 200 day moving average price of $171.33. The company has a market cap of $268.77 billion, a P/E ratio of 44.10, a PEG ratio of 2.27 and a beta of 1.77. The company has a quick ratio of 1.61, a current ratio of 2.26 and a debt-to-equity ratio of 0.37.

Lam Research (NASDAQ:LRCXGet Free Report) last released its earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.17 by $0.10. The company had revenue of $5.34 billion for the quarter, compared to analysts’ expectations of $5.23 billion. Lam Research had a return on equity of 62.81% and a net margin of 30.22%.The firm’s quarterly revenue was up 22.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.91 EPS. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. Research analysts predict that Lam Research Corporation will post 3.71 earnings per share for the current year.

Lam Research Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 8th. Shareholders of record on Wednesday, March 4th will be given a $0.26 dividend. The ex-dividend date is Wednesday, March 4th. This represents a $1.04 annualized dividend and a yield of 0.5%. Lam Research’s dividend payout ratio is presently 21.31%.

Insider Buying and Selling at Lam Research

In other news, insider Ava Harter sold 1,500 shares of the company’s stock in a transaction on Wednesday, March 4th. The shares were sold at an average price of $222.66, for a total transaction of $333,990.00. Following the transaction, the insider directly owned 53,205 shares of the company’s stock, valued at $11,846,625.30. This represents a 2.74% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Douglas R. Bettinger sold 50,057 shares of the stock in a transaction dated Wednesday, March 4th. The shares were sold at an average price of $224.03, for a total transaction of $11,214,269.71. Following the completion of the transaction, the chief financial officer owned 1,081,705 shares of the company’s stock, valued at $242,334,371.15. This represents a 4.42% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 130,886 shares of company stock valued at $29,658,802. 0.31% of the stock is owned by company insiders.

Lam Research Company Profile

(Free Report)

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.

Featured Stories

Institutional Ownership by Quarter for Lam Research (NASDAQ:LRCX)

Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.